Axis Punch: Wockhardt Ltd - 8 Th July, 2025
The company has revenues remained broadly stable, hovering between Rs 2,800 Cr and Rs 3,000 Cr annually, reflecting its shift from U.S. generics...
262 Views
#161 India Insights: India Eyes Rare Earth Push; IndusInd's Prerequisites from RBI, Insulin Scale Up
​India aims to localize rare earth magnet production for EV and tech sectors, Hinduja Group faces RBI conditions for Indusind Bank
524 Views
#160 India Insight: Adani Energy â‚ą6K Cr+ Inv, Tata Apple Repair, Maruti Suzuki Solar Boost
​Adani Energy Solutions invests INR 6,000 crore in centralised cooling, Apple appoints Tata for repairs in India, Maruti Suzuki expands solar...
467 Views
APAC Healthcare Weekly (May 11)- Shionogi, Daiichi Sankyo, HK Inno, Neuren, Biocon, Aster DM, Lupin
Shionogi is acquiring Torii Pharma. Daiichi Sankyo’s Enhertu meets key goal in breast cancer trial. HK inno got domestic approval for P3 trial of...
611 Views
APAC Healthcare Weekly (Feb 2)- Daiichi Sankyo, Eisai, Nippon Shinyaku, Shionogi, Celltrion
APAC healthcare companies continued to get approvals for new products and initiates clinical trials. The companies continued with acquisitions and...
711 Views